At the beginning of its establishment, Taitai Pharmaceutical made up its mind to transform the Chinese medicine industry by modern scientific and technological means, and set the goal of modernization of Chinese medicine production and quality control, which is the starting point for Taitai Pharmaceutical to realize modernization and innovation of Chinese medicine. The extraction process is the key to realize the modernization of traditional Chinese medicine, and the traditional extraction process can't get rid of the "coarse, big and black" products. During the period of 1993, Taitai Pharmaceutical was the first Chinese medicine factory in China to purify the effective components of traditional Chinese medicine by ultrafiltration technology. 1995, Taitai Pharmaceutical Company began to implement ISO9000 series standards for quality management and quality assurance, and passed ISO9002 international quality certification for the first time in the same industry in China in 1996+0.
Taitai Pharmaceutical Production Center in the North Zone of Shenzhen High-tech Industrial Park was completed and put into operation in 1997, covering an area of 38,000 square meters, with an investment of1300 million yuan. The pharmaceutical base was designed and constructed in strict accordance with GMP standards, and officially passed the national GMP demonstration in June 1998, which indicated that the manufacturing system and quality control system of Taitai Pharmaceutical reached the international level. In July, it was awarded the "China GMP Certification Certificate" and its logo by China Drug Certification Committee; After that, all production workshops passed the national GMP certification or review for three consecutive years; 1999 The world's first fully automatic production line of traditional Chinese medicine oral liquid with an investment of more than 80 million yuan passed the acceptance test and was officially put into production. Livzon Group was established on June 26th1985,65438+thanks to Zhuhai's reform and opening up-then it was named as Livzon Medicine Development Co., Ltd. in Zhuhai Special Economic Zone. Livzon's development has gone through several important stages-
The period of 1985- 1989 was the stage of "supporting workers through trade". Taking advantage of the geographical and policy advantages of the special zone, the group actively carried out import and export trade and accumulated necessary funds for the group's industrial development;
1990- 1992 period is the stage of "combination of technology, industry and trade". Under the guidance of the policy of "rejuvenating the enterprise through science and technology", the group developed a series of fist products represented by "Livzon Happiness", quickly occupied the market with high-tech content and effective marketing promotion means, and achieved good economic benefits, which enabled Livzon to enter the track of rapid development;
1993- 1996 is the stage of "shareholding system reform". Livzon seized the opportunity of the country's pilot joint-stock reform, relying on the advantages of good enterprise quality and its own operating performance, jumped out of the mode of relying on its own accumulation and development, and raised a lot of development funds through the joint-stock reform, laying a solid material foundation for the large-scale development of the group; At the same time, the shareholding system reform has strengthened the scientific management and capital operation of the Group, and the modern enterprise system has been fully implemented in the Group, and a management mechanism with "competition mechanism, incentive mechanism, supervision mechanism, restraint mechanism and guarantee mechanism" as the main content has been established and improved, so that the Group truly has the characteristics of modern enterprises and corresponding management capabilities;
1996-200 1 is the stage of "building a large enterprise group". 1May, 1996, the group was included in the ranks of key enterprise groups in Guangdong Province, which marked that Livzon Group entered a new development stage. The economic growth mode of the group has changed from extensive to intensive, and the economic operation mode has changed from production to capital operation. The intensive development path with "production combination, marketing specialization, scientific research marketization and logistics service socialization" as the main content has been determined, and the overall reform plan and organizational structure adjustment plan have been fully implemented.
2001-This is the second entrepreneurial stage of the enterprise. In June 2002, Health Yuan Group (formerly Taitai Pharmaceutical) entered Livzon, and private capital showed unprecedented competitive vitality. Entrepreneurs set up professional manager management independently, which greatly promoted the rapid development of enterprises. From concept innovation to mechanism innovation, from product innovation to management innovation, and finally to corporate culture innovation, Livzon's 20-year development path is Livzon's tenacious exploration and forge ahead.
Today, Livzon Group has become a comprehensive high-tech pharmaceutical enterprise group integrating scientific research, development, production and sales of pharmaceutical products, with outstanding advantages in the production and sales of prescription drugs, with 82 offices throughout the country. The market network covers 4,800 hospitals (medical institutions) at or above the county level and more than 800 pharmaceutical commercial wholesale enterprises. Livzon Group has more than 300 kinds of products, including chemicals, biochemical drugs, bioengineering drugs, microecological agents, Chinese patent medicines and diagnostic reagents. Products include digestive tract, cardiovascular and cerebrovascular diseases, anti-infection, reproductive endocrinology and other fields. The main brands of pharmaceutical preparations are Livzon Dele series, antiviral granules, Shenqi Fuzheng injection, Naolong, Livzon, Livzon Changle, Qianliean Suppository and Livzon. In addition, it also has antibiotics, statins and aminoglycosides. 38 production lines of the company and its subsidiaries have passed GMP certification, and the company itself and four holding subsidiaries have passed GSP certification.
Livzon Group adheres to the new culture of "pragmatism, innovation and high efficiency" and is committed to the evergreen cause of human life. The development strategic goal in the next five years is defined: to enter the top five pharmaceutical enterprises in China by 20 10. Shenzhen Haibin Pharmaceutical Co., Ltd. was established in 1989 with a total investment of130,000 USD, and is now a wholly-owned subsidiary of Taitai Pharmaceutical. In June 2006, 5438+0 was recognized as a high-tech enterprise in Shenzhen. Haibin Pharmaceutical Factory mainly produces anti-infective drugs. It is the first manufacturer in China to produce sulbactam sodium compound preparation on a large scale with the approval of the Ministry of Health. With mature antibiotic products, strong scientific research and development, production capacity and advanced production and testing facilities, it can produce and operate chemical raw materials, various preparations, biological products and Chinese patent medicines. It also has a synthesis workshop with an annual output of 70 tons of semi-antibiotic raw materials, with an annual output of 80 million cephalosporin powder needles and threads, with an annual output of 10.
The company has strong technical force and constantly introduces excellent new products. The series of anti-infective drugs of Haibin Pharmaceutical Company include Baneng, Haitaixin, Haishubi and Shu 'ampicillin, supplemented by antibiotic tablets, and ampicillin, amoxicillin and Shu 'ampicillin tablets. Among them, Haitaixin and Bineng are newly developed new generation antibiotics, and they obtained the new drug certificate and production approval in 1999 10 and September respectively. In 2000, new anti-tumor drugs (Topotecan for Injection), new antihypertensive drugs Sushi (Irbesartan Tablets) and new drugs Lezai (Tolterodine Tartrate) were put on the market, which greatly enhanced the sales strength of the company. Located at No.0/8, Nanxin South Street, Jinan, covering an area of 34,607 square meters. Founded in July 2003, the company is a Sino-foreign joint venture jointly invested by Shenzhen Health Pharmaceutical Group Co., Ltd., Jinan Dongfeng Pharmaceutical Factory Co., Ltd. and Hong Kong Tiancheng Industrial Co., Ltd. ..
The company can produce tablets, ointments, tinctures, soft capsules, powders, medicinal raw materials, etc. 12 dosage form 120 products. Among them, Xinfuling Cream (national new product), Quanying (levofloxacin hydrochloride dispersible tablet), Fenneco (diclofenac sodium gel) and Ganmaoling are the first in China, while almond water and tamoxifen citrate are exclusively produced in China and the province. Xinfuling cream produced by the company has been recognized by the State Science and Technology Commission, the Bureau of Foreign Experts Affairs and the Technical Supervision Bureau for its unique functions of killing mites, inhibiting bacteria, diminishing inflammation, relieving itching and caring skin and beauty. Since 1986 was put into the market, it has been well received by the majority of patients. In March 2002, the product was recognized as a well-known trademark and a unique name by Shandong Administration for Industry and Commerce. Jiaozuo Health Yuan Biological Products Co., Ltd. (hereinafter referred to as Jiaozuo Health Yuan) is jointly invested and established by Health Yuan Pharmaceutical Group Co., Ltd. and Hong Kong Tiancheng Industrial Co., Ltd., with a registered capital of 500 million yuan, of which Health Yuan Pharmaceutical Group Co., Ltd. accounts for 75% of the total investment and Tiancheng Industrial Co., Ltd. accounts for 25%. The company mainly produces 7- aminocephalosporanic acid (7-ACA), the key intermediate of cephalosporins.
In 2007, it was awarded the title of "Top 100 Enterprises in Henan Province" by the Henan Provincial Government and the titles of "High-tech Enterprise" and "Advanced Industrial Enterprise" by 20 10. In February 2007, Jiaozuo Health Yuan Biological Products Co., Ltd. established a quality management system according to the requirements of ISO900 1:2000: 2000, and a perfect quality management system according to the requirements of GMP. In June 2008, it passed the on-site audit of China Inspection and Certification Group, and obtained ISO900 1:2008: 2008 quality management system, ISO 14000 environmental management system and OHSAS 18000 occupational health and safety system certification. Health Yuan Daily Health Care Products Co., Ltd. (hereinafter referred to as Health Yuan Daily) is registered by Health Yuan Pharmaceutical Group Co., Ltd. ..
Jianyuan's daily positioning is: to provide the best quality and latest technology health care and beauty products and technologies for facial makeup line (beauty salon line). Tiancheng Industrial Co., Ltd. (hereinafter referred to as Tiancheng Industrial) was established in Hong Kong on 200 1, 19. Tiancheng Industry was established by Healthy Yuan Pharmaceutical Group Co., Ltd. and Shenzhen Haibin Pharmaceutical Co., Ltd. on June 13, 2002 with the approval of the Ministry of Foreign Economic Relations and Trade Cooperation of the People's Republic of China.
Tiancheng integrity owners should engage in business investment and other businesses. Guangdong Taitai Forensic Material Evidence Judicial Appraisal Institute is the exclusive appraisal institute of Shenzhen Taitai Genetic Engineering Co., Ltd., a subsidiary of Health Yuan Pharmaceutical Group Co., Ltd., which was approved by Guangdong Provincial Department of Justice on June 5438+February 65438+July 2002 and provided paid services to the society. The appraisal institute is rich in medical resources, and the appraisers of all professions are senior experts and professors who have been engaged in judicial appraisal for many years, with solid theoretical foundation and rich practical experience. The appraisal institute has advanced machinery and complete equipment, with high-precision instruments and equipment of16.6 million yuan and a standard experimental site of 3600 square meters. Its judicial authentication license number is 4402202. .
On April 23, 20 10, it was officially awarded the testing laboratory accreditation certificate issued by China National Accreditation Committee for Conformity Assessment; On April 29th, 20 10 officially obtained the national qualification certificate issued by China National Certification and Accreditation Administration. And in accordance with the provisions of the use of testing laboratory accreditation mark (CNAS), national qualification certification mark (CMA).